1Chen L, Kong DY, Hu G, et al. A new 9,10-dihydrophenanthrenedione from Cannabis sativa [J]. Chem Nat Comp, 2010,46(5): 710-712.
2Huestis MA. Pharmacokinetics and metabolism of the plantcannabinoids, delta9-tetrahydrocannabinol, cannabidioland cannabinol [J]. Handb Exp Pharmacol, 2005, (168):657-690.
3Deiana S, Watanabe A, Yamasaki Y, et al. Plasma andbrain pharmacokinetic profile of cannabidiol (CBD),cannabidivarine (CBDV) , A9-tetrahydrocannabivarin(THCV) and cannabigerol (CBG) in rats and mice followingoral and intraperitoneal administration and CBD action onobsessive-compulsive behaviour [J]. Psychopharmacology(Berl), 2012, 219(3) :859-873.
4Paudel KS, Hammell DC, Agu RU, et al. Cannabidiolbioavailability after nasal and transdermal application: effectof permeation enhancers [J]. Drug Dev Ind Pharm, 2010,36(9): 1088-1097.
